RVW1.F PHYSIOMICS PLC LS -004

Healthcare Biotechnology Frankfurt Exchange
0.0046 EUR
Close of Nov 12, 2026
0.0005 0.0045
Market cap
EUR 2.09M
P/E
-
P/B
0.36x
ROE
-133.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is RVW1.F undervalued?

Graham number

The Graham number of PHYSIOMICS PLC LS -004 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PHYSIOMICS PLC LS -004 fundamental analysis

No fundamental analysis for PHYSIOMICS PLC LS -004 yet.

PHYSIOMICS PLC LS -004 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PHYSIOMICS PLC LS -004

Physiomics Plc engages in the provision of consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the f…

Full company profile